Most recently, Welch was the chief financial officer at Cerimon Pharmaceuticals, a Pharmaceutical company engaged in developing pain products.
Prior to joining, Cerimon, Welch was the chief financial officer and corporate secretary at Rigel Pharmaceuticals.
AcelRx president and CEO Richard King said that Jim brings over two decades’ experience in financial and operational management at life science and high technology firms.
AcelRx Pharmaceuticals is a pharmaceutical company engaged in the development and commercialisation of products for the treatment of painful conditions where currently available treatments are not optimal.